Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991

Leukemia volume 14, pages 2240–2246 (2000)Cite this article

Abstract

Here we report the long-term results of the DCLSG protocols ALL-6 and -7 with special emphasis on the incidence of CNS relapse after treatment without cranial irradiation. In DCLSG protocol ALL-6 (1984–1988), designed for patients with ALL non-high risk (ALL-NHR) (WBC <50 × 109/l, no mediastinal mass, no B cell phenotype and no CNS involvement at diagnosis, comprising 71% of all ALL patients), CNS prophylaxis consisted of a combination of three methods of chemotherapeutic CNS prophylaxis (the use of dexamethasone during induction and maintenance therapy, i.v. medium dose methotrexate and prolonged administration of intrathecal triple therapy). Total duration of treatment: 116 weeks. 190 patients were enrolled in the study. At 10 years, the EFS rate for all patients is 81.5 ± 2.8%, the survival rate 84.8 ± 2.7%, and the cumulative incidence of isolated CNS relapse 1.1 ± 0.8%. The 10-year survival rate for the 139/190 (73.1%) patients with standard risk non-T lineage ALL according to the NCI risk criteria is 80.5 ± 3.4%. DCLSG protocol-7 was identical to the intensive ALL-BFM-86 protocol, but cranial irradiation was restricted to patients with initial CNS involvement. Patients were stratified into three risk groups (SRG, RG and EG). Treatment duration was 18 months. 218 patients were enrolled in the study. At 10 years, the EFS rate for all patients is 63.4 ± 3.3%, the survival rate 76.4 ± 3.0%, the 5-year cumulative incidence of isolated CNS relapse 5.7 ± 1.8%. The EFS rate at 10 years of the 127/218 (58.3%) patients with standard risk non-T-lineage ALL according to the NCI risk criteria was 67.9 ± 4.3%, which is not significantly different from the results achieved in this category of patients with the moderately intensive treatment according to protocol ALL-6 (logrank P = 0.17). These DCLSG studies indicate that omission of cranial irradiation does not jeopardize the overall good results.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Riehm H, Feickert HJ, Schrappe M, Henze G, Schellong G . Therapy results in five ALL-BFM studies since 1970. Complications of risk factors for prognosis Hamatol Bluttransfus 1987 30: 139–146

    CAS  Google Scholar 

  2. Langermann HJ, Henze G, Wulf M, Riehm H . Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämie im Kindersalter: Prognostische Bedeutung und praktische Anwendung Klin Pädiat 1982 194: 209–213

    Article  CAS  Google Scholar 

  3. Masera G, Gadner H, Kamps WA, Otten J, Philippe N, Schuler D, Riehm H . The treatment of childhood acute lymphoblastic leukemia Int J Pediatr Hematol/Oncol 1998 5: 141–144

    Google Scholar 

  4. Van der Does-van den Berg A, Bartram CR, Basso G, Benoit A, Haas OA, Harbott J, Kamps WA, Köller U, Lampert F, Ludwig W-D, Niemeyer CM, van Wering ER . Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood ALL in the ‘BFM Family’ Cooperative Group Med Pediatr Oncol 1992 20: 497–505

    Article  CAS  Google Scholar 

  5. Reiter A, Schrappe M, Ludwig W, Hiddemann W, Sauter S, Henze G, Zimmermann M, Odenwald E, Ritter J, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients Blood 1994 84: 3122–3133

    Article  CAS  Google Scholar 

  6. Veerman AJP, Hählen K, Kamps WA, Van Leeuwen EF, De Vaan GAM, Solbu G, Suciu S, Van Wering ER, Van der Does-van den Berg A . High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group J Clin Oncol 1996 14: 911–918

    Article  CAS  Google Scholar 

  7. Kamps WA, Bökkerink JPM, Hählen K, Riehm H, Gadner H, Schrappe M, Slater R, Van den Berg-de Ruiter E, Smets LA, De Vaan GAM, Weening RS, Van Weerden JF, Van Wering ER, Van der Does-van den Berg A . Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM 86 without cranial radiotherapy: results of DCLSG Protocol ALL-7 (1988–1991) Blood 1999 94: 1226–1236

    CAS  PubMed  Google Scholar 

  8. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui-C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18–24

    Article  CAS  Google Scholar 

  9. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C . Proposals for the classification of the acute leukaemias Br J Haematol 1976 33: 451–459

    Article  CAS  Google Scholar 

  10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, the French–American–British (FAB) Cooperative Group . The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations Br J Haematol 1981 47: 553–561

    Article  CAS  Google Scholar 

  11. Veerman AJP, Huismans DR, Van Zantwijk CH . Storage of cerebrospinal fluid samples at room temperature Acta Cytol 1985 29: 188–189

    CAS  PubMed  Google Scholar 

  12. Van Wering ER, Veerman AJP, Van der Linden-Schrever BEM . Diagnosis of meningeal involvement in childhood acute lymphoblastic leukemia: cytomorphology and TdT Eur J Haematol 1988 40: 250–255

    Article  CAS  Google Scholar 

  13. Slater RM, Smeets DFCM, Hagemeijer A, De Jong B, Beverstock CG, Geraedts JPM, Van der Does-van den Berg A, Van Wering ER, Veerman AJP . Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study Group Hamatol Bluttransfus 1990 33: 169–173

    CAS  Google Scholar 

  14. Kalbfleisch JD, Prentice RL . The Statistical Analysis of Failure Time Data John Wiley: New York 1980 pp 163–188

  15. Sluis van der IM, Heuvel van den MM, Hählen K, Krenning EP, Muinck Keizer-Schrama de SMPF . Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood Med Pediatr Oncol 1999 33: 247 (Abstr.)

    Google Scholar 

  16. Conter V, Schrappe M, Aricò M, Reiter A, Rizzari C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig W-D, Basso G, Masera G, Riehm H for the Associazone Italiana Ematologia Oncologia Pedriatrica and the Berlin–Frankfurt–Munster Groups . Role of cranial radiotherapy for childhood T cell acute lymphoblastic leukemia with high WBC count and good response to prednisone J Clin Oncol 1997 15: 2786–2791

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dutch Childhood Leukemia Study Group (DCLSG), The Hague, The Netherlands

    WA Kamps, AJP Veerman, ER van Wering, JF van Weerden & A van der Does-van den Berg

  2. Beatrix Children's Hospital, University Hospital, Groningen, The Netherlands

    WA Kamps

  3. Department of Pediatrics, University Hospital Vrije Universiteit, Amsterdam, The Netherlands

    AJP Veerman

  4. Department of Clinical Genetics/Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands

    R Slater

  5. Dutch Workgroup on Cancer Genetics and Cytogenetics (NWKGC),

    R Slater

Authors
  1. WA Kamps
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. AJP Veerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. ER van Wering
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JF van Weerden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Slater
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A van der Does-van den Berg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kamps, W., Veerman, A., van Wering, E. et al. Long-term follow-up of Dutch Childhood Leukemia Study Group (DCLSG) protocols for children with acute lymphoblastic leukemia, 1984–1991. Leukemia 14, 2240–2246 (2000). https://doi.org/10.1038/sj.leu.2401964

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2401964

Keywords

This article is cited by

Search

Advanced search

Quick links